Agios Pharmaceuticals (AGIO) Revenue (2012 - 2026)
Agios Pharmaceuticals (AGIO) posted Revenue of $44.75 million for Q2 2026, up 259.3% from $12.46 million a year earlier and up 115.7% from the prior quarter.
Agios Pharmaceuticals (AGIO) Revenue (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Revenue at Agios Pharmaceuticals was $98.34 million, up 140.6% year-over-year; for FY2025, it was $54.03 million, up 48.0% from FY2024.
- Annual Revenue has increased for three consecutive years, with a three-year compound annual growth rate of 56.0% (FY2022 to FY2025).
- In prior years, Agios Pharmaceuticals' Revenue was $36.5 million in FY2024 (+36.1%), $26.82 million in FY2023 (+88.4%) and $14.24 million in FY2022.
- The Q2 2026 figure stands as the highest quarterly Revenue since Q1 2020.
- On a year-over-year basis, Revenue has increased in each of the last 14 quarters, with growth averaging 81.3% over the last eight quarters.
- Over the past five years, the year-over-year growth in Revenue ranged from 6.6% (Q1 2025) to 574.2% (Q1 2023).
- According to Business Quant data, Revenue for the three prior quarters was $20.75 million (Q1 2026), $19.97 million (Q4 2025) and $12.88 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 24.40 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 17.40 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 18.09 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 15.07 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 16.58 Bn |
| 10 | Agios Pharmaceuticals | 1.90 Bn | -940.41 Mn | 52.86 Mn | 55.39 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 55.39 Mn |
| Jun 30, 2026 | 44.75 Mn |
| Mar 31, 2026 | 20.75 Mn |
| Dec 31, 2025 | 19.97 Mn |
| Sep 30, 2025 | 12.88 Mn |
| Jun 30, 2025 | 12.46 Mn |
| Mar 31, 2025 | 8.73 Mn |
| Dec 31, 2024 | 10.73 Mn |
| Sep 30, 2024 | 8.96 Mn |
| Jun 30, 2024 | 8.62 Mn |
| Mar 31, 2024 | 8.19 Mn |
| Dec 31, 2023 | 7.10 Mn |
| Sep 30, 2023 | 7.40 Mn |
| Jun 30, 2023 | 6.71 Mn |
| Mar 31, 2023 | 5.61 Mn |
| Dec 31, 2022 | 4.31 Mn |
| Sep 30, 2022 | 3.52 Mn |
| Jun 30, 2022 | 5.58 Mn |
| Mar 31, 2022 | 832,000.00 |
| Dec 31, 2020 | 44.05 Mn |
Agios Pharmaceuticals Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=AGIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "AGIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=AGIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();